Characteristics of ALZ treatments performed in patients with AA
| N = 64 treatments . | Value . |
|---|---|
| ALZ dose, n (%) | |
| 103 mg | 43 (67) |
| 73 mg | 8 (13) |
| 120 mg | 5 (8) |
| 100 mg | 6 (9) |
| 150 mg | 2 (3) |
| Line of treatment using ALZ, n (%) | |
| First line | 37 (58) |
| Second line | 17 (26) |
| ≥Third | 10 (16) |
| Time from diagnosis to ALZ treatment, median (range), mo | 8 (0.4-294) |
| N = 64 treatments . | Value . |
|---|---|
| ALZ dose, n (%) | |
| 103 mg | 43 (67) |
| 73 mg | 8 (13) |
| 120 mg | 5 (8) |
| 100 mg | 6 (9) |
| 150 mg | 2 (3) |
| Line of treatment using ALZ, n (%) | |
| First line | 37 (58) |
| Second line | 17 (26) |
| ≥Third | 10 (16) |
| Time from diagnosis to ALZ treatment, median (range), mo | 8 (0.4-294) |